SANTONI, ADELE
 Distribuzione geografica
Continente #
EU - Europa 1.404
NA - Nord America 1.145
AS - Asia 681
SA - Sud America 128
AF - Africa 53
OC - Oceania 4
Totale 3.415
Nazione #
US - Stati Uniti d'America 1.101
RU - Federazione Russa 415
IT - Italia 253
SG - Singapore 201
IE - Irlanda 180
CN - Cina 164
DE - Germania 147
GB - Regno Unito 122
BR - Brasile 107
VN - Vietnam 81
FI - Finlandia 79
FR - Francia 73
HK - Hong Kong 59
SE - Svezia 55
CA - Canada 30
IN - India 28
ZA - Sudafrica 28
KR - Corea 26
BD - Bangladesh 21
PK - Pakistan 17
PL - Polonia 17
NL - Olanda 16
IR - Iran 12
CZ - Repubblica Ceca 10
EG - Egitto 9
IQ - Iraq 9
AR - Argentina 8
ES - Italia 8
JP - Giappone 8
MX - Messico 8
AT - Austria 6
SA - Arabia Saudita 6
UA - Ucraina 6
UZ - Uzbekistan 6
CO - Colombia 5
ID - Indonesia 5
TR - Turchia 5
AU - Australia 4
MA - Marocco 4
BO - Bolivia 3
KH - Cambogia 3
MY - Malesia 3
NG - Nigeria 3
NP - Nepal 3
PH - Filippine 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EC - Ecuador 2
ET - Etiopia 2
GR - Grecia 2
KE - Kenya 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
OM - Oman 2
PY - Paraguay 2
AL - Albania 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NI - Nicaragua 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 3.415
Città #
Dallas 234
Dublin 179
Singapore 126
Ashburn 116
Munich 114
Moscow 109
San Jose 99
Southend 81
Santa Clara 68
Helsinki 63
Hong Kong 55
Chandler 48
Hefei 46
Siena 44
Beijing 39
Los Angeles 36
New York 36
Fairfield 33
Florence 31
Milan 28
Johannesburg 26
Ho Chi Minh City 25
Lauterbourg 25
Hanoi 24
Seoul 24
The Dalles 22
Council Bluffs 20
Seattle 19
Princeton 18
Woodbridge 16
Shanghai 15
Rome 14
Houston 13
Warsaw 13
Wilmington 13
Turin 12
Cambridge 11
Chennai 10
Washington 10
Buffalo 9
Frankfurt am Main 9
London 9
Portsmouth 9
São Paulo 9
Toronto 9
Turku 9
Brooklyn 8
Montreal 8
Chicago 7
Denver 7
Messina 7
Orem 7
Redondo Beach 7
Tokyo 7
Bengaluru 6
Fremont 6
Tashkent 6
Baghdad 5
Haiphong 5
Lappeenranta 5
San Diego 5
San Francisco 5
Stockholm 5
Atlanta 4
Brno 4
Da Nang 4
Düsseldorf 4
Fano 4
Guarulhos 4
Mumbai 4
Nuremberg 4
Olomouc 4
Phoenix 4
Rio de Janeiro 4
San Mateo 4
Abuja 3
Ann Arbor 3
Biên Hòa 3
Boston 3
Brescia 3
Buscate 3
Cairo 3
Dammam 3
Genova 3
Grosseto 3
Hangzhou 3
Kensington 3
La Paz 3
Montecatini Terme 3
Morrinhos 3
Ottawa 3
Paris 3
Phnom Penh 3
Poplar 3
Porto Alegre 3
Querétaro 3
Ribeirão Preto 3
Shenzhen 3
Vancouver 3
Abidjan 2
Totale 2.206
Nome #
Circulating CD34+/CD38-/CD26+ Leukemia Stem Cells along Chronic Myeloid Leukemia progression: differences between Chronic, Accelerated and Blast Phase 299
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 290
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma 227
A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid? 220
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia 216
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 208
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma 202
Anti CD38 monoclonal antibodies for multiple myeloma treatment 195
Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience 194
Fludarabine, high-dose cytarabine and idarubicin-based induction may overcome the negative prognostic impact of FLT3-ITD in NPM1 mutated AML, irrespectively of FLT3-ITD allelic Burden 178
Prospective monitoring of Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation: the fate of Peripheral Blood CD26+ Leukemia Stem Cells 173
Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant) 163
Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS) 153
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 147
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 142
Infectious complications after induction chemotherapy with FLAI(E) in newly diagnosed AML, omitting antibacterial prophylaxis 131
Prognostic value of CD47 overexpression measured by flow cytometry in acute myeloid leukemia 130
Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study 86
IDENTIFICATION OF LEUKEMIC STEM CELLS IN AML PATIENTS BY USING NEXT-GENERATION FLOW: A PERSONALIZED BIOMARKER OF PROGNOSIS AND PROGRESSION 60
Reply to “Peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia and tyrosine kinase inhibitor response: Questions remain!” 26
Allogeneic hematopoietic stem cell transplantation despite severe Fusarium solani infection in a lung transplanted patient. A case report 23
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM 16
Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype 13
Totale 3.492
Categoria #
all - tutte 12.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 0 15
2021/2022167 4 22 14 16 4 5 5 7 8 17 29 36
2022/2023257 12 38 30 27 8 31 4 20 16 4 54 13
2023/2024429 16 13 42 29 36 99 123 14 9 21 7 20
2024/2025775 17 19 78 34 69 63 81 74 95 42 83 120
2025/20261.719 101 199 216 241 381 64 155 44 87 136 54 41
Totale 3.492